Soterius

Princeton, United States Founded: 2018 • Age: 8 yrs
Pharmacovigilance, medical affairs, and drug safety services are provided.
Annual revenue $619,023 Latest available
Total funding $1.5M 1 rounds
Employees 41 Tracked headcount
Investors 1 Known backers
Products 4 Services tracked
Competitors 8 Brand Intelligence

About Soterius

Soterius is a company based in Princeton (United States) founded in 2018 by Suneet Walia. It operates as a Managed Services and HealthTech. Soterius has raised $1.5 million across 1 funding round from investors including Celegence. The company has 41 employees as of April 05, 2024. Soterius offers products and services including Clinical Safety Services, Postmarketed Pharmacovigilance Services, Medical Affairs and Writing, and UNITY™dx Platform. Soterius operates in a competitive market with competitors including SFL Regulatory Affairs & Scientific Communication, Scinopsis, InfocusRx, Regulatory Professionals and AxPharma, among others.

  • Headquarter Princeton, United States
  • Employees 41 as on 05 Apr, 2024
  • Founders Suneet Walia
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Soterius Life Sciences India Private Limited
  • Date of Incorporation 26 Dec, 2018
  • Jurisdiction Delhi, Delhi, India
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $619.02 K (USD)
    25.87
    as on Mar 31, 2022
  • Net Profit
    $29.16 K (USD)
    74.65
    as on Mar 31, 2022
  • EBITDA
    $47.42 K (USD)
    60.08
    as on Mar 31, 2022
  • Total Equity Funding
    $1.5 M (USD)

    in 1 rounds

  • Latest Funding Round
    $1.5 M (USD), Series A

    Mar 06, 2020

  • Investors
  • Employee Count
    41

    as on Apr 05, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Soterius

Soterius offers a comprehensive portfolio of products and services, including Clinical Safety Services, Postmarketed Pharmacovigilance Services, Medical Affairs and Writing, and UNITY™dx Platform.

Product name locked
Category locked
Primary

Clinical safety services are provided for drug monitoring.

Product name locked
Category locked
Locked

Postmarket drug safety monitoring services are offered globally.

Product name locked
Category locked
Locked

Medical information and writing support are delivered internationally.

Product name locked
Category locked
Locked

Technology platform for drug safety is developed innovatively.

People of Soterius

Headcount 10-50
Employee Profiles 18
Board Members and Advisors 6
Employee Profiles
People
Tanvi Chaturvedi
Senior Manager, Clinical Safety & Pharmacovigilance
People
Mani Agnihotri
Senior Associate - Clinical Safety And Pharmacovigilance
People
Sumit Verma
SVP, Safety Operations
People
Bhumi Vyas
Head, Corporate Quality Assurance

Unlock access to complete

Board Members and Advisors
people
Rakesh Dighe
Board Member
people
Bharti Khanna
Advisor
people
Hal Ward
Advisor
people
Arun Purohit
Advisor

Unlock access to complete

Funding Insights of Soterius

Soterius has successfully raised a total of $1.5M through 1 strategic funding round. The most recent funding activity was a Series A round of $1.5 million completed in March 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Soterius

Soterius has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Celegence.

All
Institutional
Investor Description Founded Year Domain Location
Regulatory consulting and solutions for pharmaceuticals and medical devices compliance.
Locked Locked Locked
Premium access

Investor details for Soterius

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Soterius

Investments
Premium access

Investment portfolio details for Soterius

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Soterius

Premium access

Detailed financials for Soterius

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Soterius Comparisons

Soterius Primary company
Description
Pharmacovigilance, medical affairs, and drug safety services...
Location
Princeton, United States
Founded Year
2018
Annual Revenue
$619.02 K (USD)
Net Profit
$29.16 K (USD)
EBITDA
$47.42 K (USD)
Employees
41
As of 2024
Premium access

Peer comparison for Soterius

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Soterius

Soterius operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SFL Regulatory Affairs & Scientific Communication, Scinopsis, InfocusRx, Regulatory Professionals and AxPharma, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Consulting services in regulatory affairs and scientific communication are provided.
Locked Locked Locked
Semiconductor and power electronic devices are manufactured for various sectors.
Locked Locked Locked
Offers branding, digital marketing, and knowledge services for healthcare industries.
Locked Locked Locked
Regulatory consulting services for medical writing and strategies are provided.
Locked Locked Locked
Provider of vigilance, case treatment, and medical writing services for life science companies
Premium access

Detailed competitors of Soterius

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Soterius

Premium access

Complete news archive for Soterius

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Soterius

Soterius was founded in 2018 and raised its 1st funding round 2 years after it was founded.

Soterius is headquartered in Princeton, United States. It is registered at Princeton, New Jersey, United States.

Suneet Walia is the current CEO of Soterius. They have also founded this company.

Soterius is a funded company, having raised a total of $1.5M across 1 funding round to date.

As of Apr 05, 2024, the latest employee count at Soterius is 41.

Annual revenue of Soterius is $619.02K as on Mar 31, 2022.

Soterius is involved in providing pharmacovigilance, clinical safety, and medical affairs services to the pharmaceutical industry. Solutions are offered across multiple geographies, supporting regulatory compliance and drug safety through innovative technology platforms like UNITYdx. Services include clinical SAE processing, medical literature monitoring, and risk management plans. The company operates in the healthcare sector, focusing on enhancing data transparency and compliance for global and local pharmaceutical clients.

Soterius offers Clinical Safety Services, Postmarketed Pharmacovigilance Services, Medical Affairs and Writing, and UNITY™dx Platform.

Soterius has 1 investor. Key investors include Celegence.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available